Literature DB >> 8447401

Dual effects of cisapride on gastric emptying and antropyloroduodenal motility.

R Fraser1, M Horowitz, A Maddox, J Dent.   

Abstract

There is little information about the effects of cisapride on human antropyloroduodenal motility, despite its documented efficacy for increasing the rate of gastric emptying in patients with gastroparesis. Cisapride has been reported to have little effect on gastric emptying in normal subjects. Antral, pyloric, and duodenal pressures were recorded simultaneously with gastric emptying in 20 healthy volunteers. Thirty minutes after the solid component of the meal had started to empty from the stomach, each subject received either 10 mg cisapride i.v. (11 subjects) or intravenous saline (9 subjects). Intravenous saline had no effect on either motility or gastric emptying. In contrast, cisapride administration was associated with a dual effect on motility, with initial suppression of antral pressure waves (P < 0.05) followed by stimulation of associated antropyloroduodenal pressure waves (P < 0.01). Gastric emptying slowed in the first 30 min after cisapride (P < 0.05), and this was followed by more rapid gastric emptying (P < 0.01). The amount of the meal emptied in the 60 min after cisapride correlated with the number of associated antroduodenal pressure waves (r = 0.75, P < 0.001) but not with the number of antral waves (r = 0.42, NS). These results indicate that cisapride in a dose of 10 mg i.v. has dual effects on gastric emptying and gastric motility. The stimulation of associated antral pressure waves is a plausible mechanism for the efficacy of cisapride in the treatment of gastroparesis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8447401     DOI: 10.1152/ajpgi.1993.264.2.G195

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  17 in total

1.  Characterization of small intestinal pressure waves in ambulant subjects recorded with a novel portable manometric system.

Authors:  M Samsom; R Fraser; A J Smout; M A Verhagen; K Adachi; M Horowitz; J Dent
Journal:  Dig Dis Sci       Date:  1999-11       Impact factor: 3.199

2.  Postprandial transduodenal bolus transport is regulated by complex peristaltic sequence.

Authors:  Huan Nam Nguyen; Ron Winograd; Gerson Ricardo Souza Domingues; Frank Lammert
Journal:  World J Gastroenterol       Date:  2006-10-07       Impact factor: 5.742

Review 3.  Management of gastrointestinal motility disorders. A practical guide to drug selection and appropriate ancillary measures.

Authors:  J R Malagelada; E Distrutti
Journal:  Drugs       Date:  1996-10       Impact factor: 9.546

Review 4.  New developments in the treatment of functional dyspepsia.

Authors:  Vincenzo Stanghellini; Fabrizio De Ponti; Roberto De Giorgio; Giovanni Barbara; Cesare Tosetti; Roberto Corinaldesi
Journal:  Drugs       Date:  2003       Impact factor: 9.546

5.  Selective stimulation of colonic transit by the benzofuran 5HT4 agonist, prucalopride, in healthy humans.

Authors:  E P Bouras; M Camilleri; D D Burton; S McKinzie
Journal:  Gut       Date:  1999-05       Impact factor: 23.059

Review 6.  Role and integration of mechanisms controlling gastric emptying.

Authors:  M Horowitz; J Dent; R Fraser; W Sun; G Hebbard
Journal:  Dig Dis Sci       Date:  1994-12       Impact factor: 3.199

7.  Postprandial antropyloroduodenal motility and gastric emptying in gastroparesis--effects of cisapride.

Authors:  R J Fraser; M Horowitz; A F Maddox; J Dent
Journal:  Gut       Date:  1994-02       Impact factor: 23.059

Review 8.  Diagnosis and treatment of neuromuscular disorders of the stomach.

Authors:  Kenneth L Koch
Journal:  Curr Gastroenterol Rep       Date:  2003-08

Review 9.  A risk-benefit assessment of cisapride in the treatment of gastrointestinal disorders.

Authors:  J Tack; G Coremans; J Janssens
Journal:  Drug Saf       Date:  1995-06       Impact factor: 5.606

Review 10.  Disordered gastric motor function in diabetes mellitus.

Authors:  M Horowitz; R Fraser
Journal:  Diabetologia       Date:  1994-06       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.